
Alpa Laboratories Ltd is Rated Strong Sell
2026-04-28 10:10:03Alpa Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Alpa Laboratories Ltd is Rated Strong Sell
2026-04-17 10:10:03Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Alpa Laboratories Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent
2026-04-06 13:00:06At Rs 62.10, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Alpa Laboratories Ltd locked at its upper circuit of 20% on 6 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Alpa Laboratories Ltd is Rated Strong Sell
2026-04-06 10:10:15Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Alpa Laboratories Ltd Falls to 52-Week Low of Rs 54.1 as Sell-Off Deepens
2026-03-27 13:42:51For the fifth consecutive session, Alpa Laboratories Ltd closed lower, hitting a fresh 52-week low of Rs 54.1 on 27 Mar 2026. This marks a steep 54.5% decline from its 52-week high of Rs 118.8, underscoring sustained selling pressure amid a challenging market backdrop.
Read full news article
Alpa Laboratories Ltd is Rated Strong Sell
2026-03-26 10:10:14Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Markets Rally, But Alpa Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-03-23 14:10:38Despite a broader market rally, Alpa Laboratories Ltd has plunged to its lowest price in 52 weeks, closing near Rs 54.56 on 23 Mar 2026. This decline comes amid a backdrop of weakening financial performance and persistent selling pressure that has pushed the stock down by nearly 49% over the past year.
Read full news article
Alpa Laboratories Ltd Stock Hits 52-Week Low Amid Continued Downtrend
2026-03-17 16:00:23Alpa Laboratories Ltd has reached a new 52-week low, reflecting a sustained decline in its share price amid broader market gains. The stock’s recent performance highlights ongoing concerns within the Pharmaceuticals & Biotechnology sector, with the share price now trading below all key moving averages.
Read full news articleAppointment of Company Secretary and Compliance Officer
11-Apr-2026 | Source : BSEAppointment of Ms.Yashoda Patidar as the Company Secretary and Complaince Officer of the company w.e.f. April 112026.
Clarification
09-Apr-2026 | Source : BSEClarification on the Price Sensitive Information via email dt8th April2026
Clarification Sought from Alpa Laboratories Ltd
08-Apr-2026 | Source : BSEThe Exchange has sought clarification from Alpa Laboratories Ltd on April 8 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
The reply is awaited.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available







